Cytokinetics, Inc. (CYTK) Posts Q1 Loss of 27c/Share
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $67.59 +0.04%
EPS Growth %: +43.1%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +43.1%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.27), $0.07 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $8 million versus the consensus estimate of $7.69 million.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Sun Communities completes $1.03B sale of Park Holidays to Aermont
- Progress Software completes $400M acquisition of Domo's data platform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
